Table 1.

Baseline Patient Characteristics.

Number of females/males	42/14
Age, years (range)	61.3 (48 to 74)
Steinbrocker stage	I: 21, II: 16, III: 3, IV: 16
Steinbrocker class	1: 27, 2: 28
Disease duration, years (range)	7.5 (0.6 to 14.9)
PSL dose, mg/day (range)	4.2 (3.0 to 5.5)
Number of patients treated with PSL	37
MTX dose, mg/week (range)	7.5 (4.0 to 10.5)
Number of patients treated with MTX	56
Number of patients treated with SASP	9
Number of patients treated with BUC	1
Number of patients treated with TAC	8
Number of patients treated with IFX	10
Number of patients treated with ETN	4
Number of patients treated with TCZ	1
Number of patietns treated with ABT	3

MTX: methotrexate, PSL: prednisolone, SASP: salazosulfapyridine, BUC: bucillamine, TAC: tacrolimus, IFX: infliximab, ETN: etanercept, TCZ: tocilizumab, ABT: abatacept